Understanding the impact of advertising on reduced harm tobacco products
Project 2: The effects of advertising and correctives for reduced harm tobacco products
This study looks at how ads for safer tobacco products affect what smokers and former smokers think and do, helping to clear up any misunderstandings about these products.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10478092 on NIH RePORTER |
What this research studies
This research investigates how advertising for reduced harm tobacco products, known as Modified Risk Tobacco Products (MRTPs), influences consumer beliefs and behaviors. It aims to identify misleading claims made in advertisements and their effects on both current smokers and former smokers. By employing rigorous scientific methods, the project seeks to understand the relationship between these beliefs and the likelihood of using these products. The findings will help develop effective corrective communications to address misconceptions.
Who could benefit from this research
Good fit: Ideal candidates for this research include current smokers and former smokers who may be influenced by tobacco advertising.
Not a fit: Patients who do not use tobacco products or have never smoked may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to better-informed consumers and reduced harm from tobacco product use.
How similar studies have performed: Previous research has shown that advertising significantly impacts consumer perceptions, suggesting that this approach could yield valuable insights.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Cappella, Joseph Nicholas — University of Pennsylvania
- Study coordinator: Cappella, Joseph Nicholas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.